Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis
NCT ID: NCT04395040
Last Updated: 2021-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2020-05-08
2020-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some older, younger people have lived in a world where cancer was little talked about, where there was little treatment possible.
There is an idea that doctors are not very quick to start curative treatment because they think that the elderly cannot bear it.
It is important to differentiate screening and early diagnosis.
Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor, leading to urgent management.
The elderly are often excluded from clinical studies.
In addition, the geriatric population is heterogeneous, leading to very diverse and individual care, with prioritization of issues.
Oncogeriatrics, which combines two services (oncology and geriatrics), is a specialized discipline, promoting comprehensive care for the elderly patient with cancer.
The general practitioner is at the center of care. It detects early signs and starts examinations if necessary.
Cancer care can be divided up with the different stages of care with various teams, including organ specialists.
The general practitioner is the privileged interlocutor for the patient and their family (medico-psycho-social plan), who knows their history and their experience.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization and Improvement of Care Course for 75 Years and Over Patient With Cancer and Living in Nursing Home on the Marseille Agglomeration
NCT03103659
Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological Malignancy
NCT03960593
Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' With Cancer
NCT03659123
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
NCT00769951
Validation of a Screening Tool in Geriatric Oncology
NCT00963911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Elderly patients with digestive cancer or breast cancer.
Semi-structured interview
Semi-structured interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Semi-structured interview
Semi-structured interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incident diagnosis
* Has cancer whose diagnosis dates back more than 3 months
* Digestive cancer, breast cancer
* Stage of advanced cancer (TNM stage: T\> T2 (terminal included), M1)
* According to the opinion of the oncogeriatrician on the time of taking charge
* Follow-up of a geriatrics service, onco-geriatrics orientation
* Living in the Rhône department
* Non-opposition of the patient to the study
Exclusion Criteria
* Patient denies
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Camille TAZELMATI, MD Student
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Marie VALERO, MD
Role: STUDY_DIRECTOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Léon Bérard
Lyon, , France
Hôpital Lyon Sud
Pierre-Bénite, , France
Centre hospitalier Fleyriat
Viriat, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL19_0731
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.